AstraZeneca CEO Pascal Soriot and Prince Charles at the official opening of the pharma's new global research and development facility at the Cambridge Biomedical Campus (Chris Jackson/Getty Images)

Pas­cal So­ri­ot's big year at the helm of As­traZeneca is crowned with a knight­hood

Pas­cal So­ri­ot’s vic­to­ry lap lead­ing up to his 10th an­niver­sary as CEO of a rad­i­cal­ly trans­formed As­traZeneca comes with a knight­hood.

So­ri­ot — born and raised in France, head of a Cam­bridge, UK-based phar­ma gi­ant and a cit­i­zen of Aus­tralia — re­ceived the knight­hood in the Queen’s Birth­day Ho­n­ours 2022 for ser­vices ren­dered dur­ing the glob­al out­break of Covid-19.

While se­vere­ly ham­pered in the US and Eu­rope by ear­ly safe­ty frets, As­traZeneca went on to dis­trib­ute one of the most wide­ly used vac­cines de­vel­oped against the virus — much of it at cost af­ter a break­neck de­vel­op­ment pro­gram. And the com­pa­ny al­so de­vel­oped the Evusheld an­ti­body. But the knight­hood can al­so be seen as a tac­it recog­ni­tion that So­ri­ot kept his promise to re­make As­traZeneca when he stepped up to the helm of the weak­est play­er among the top 10 phar­mas in the world.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.